Clinical Trial Update: Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing octreotide to placebo for inoperable bowel obstruction due to peritoneal carcinomatosis has been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Obstruction
• Peritoneal Carcinomatosis

Drugs mentioned

• Sandostatin (Octreotide acetate)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Peritoneal Neoplasms, Intestinal Obstruction | Phase 2 | Status: COMPLETED | Results posted: 2011-06-15